Compare ECOR & TISI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ECOR | TISI |
|---|---|---|
| Founded | 2005 | 1973 |
| Country | United States | United States |
| Employees | N/A | 6800 |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.6M | 101.4M |
| IPO Year | 2018 | 1995 |
| Metric | ECOR | TISI |
|---|---|---|
| Price | $9.50 | $27.70 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $18.00 | N/A |
| AVG Volume (30 Days) | ★ 95.4K | 28.9K |
| Earning Date | 05-06-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $32,032,000.00 | ★ $896,483,000.00 |
| Revenue This Year | $33.60 | N/A |
| Revenue Next Year | $30.40 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 27.20 | 5.19 |
| 52 Week Low | $4.41 | $12.34 |
| 52 Week High | $10.95 | $26.76 |
| Indicator | ECOR | TISI |
|---|---|---|
| Relative Strength Index (RSI) | 56.76 | 79.40 |
| Support Level | $5.70 | $13.58 |
| Resistance Level | $10.60 | N/A |
| Average True Range (ATR) | 0.80 | 1.23 |
| MACD | -0.14 | 0.30 |
| Stochastic Oscillator | 43.30 | 100.00 |
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.
Team Inc provides specialty industrial services, including inspection, engineering assessment, and mechanical repair and remediation required in maintaining high-temperature and high-pressure piping systems and vessels utilized in refining, petrochemicals, and others. The company operates in two segments, Inspection and Heat Treating and Mechanical Services. The Inspection and Heat Treating segment, which generates maximum revenue, provides conventional and non-destructive testing services for the process, pipeline, and power sectors, pipeline integrity management services, and field heat treating services, as well as associated engineering and condition assessment services. Geographically, the company derives its key revenue from the United States, followed by other countries, and Canada.